Gene therapy for L-amino acid decarboxylase deficiency in children

Takeaway

  • Gene therapy in children with L-amino acid decarboxylase (AADC) deficiency increases fractional anisotropy (FA) levels, which is linked to improved motor function despite lack of obvious structural changes.

Why this matters ?

  • AADC plays an integral role in dopamine and serotonin production, with deficiency resulting in severe motor dysfunction; findings validate a new technique that could serve of great benefit to children responding poorly to established therapies.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.